CRP and non-small cell lung carcinoma: Mitsuyoshi et al. [92] investigated the prognostic value of the CRP-BMI score, derived from C-reactive protein (CRP) levels and the body mass index (BMI), for patients with locally advanced non-small cell lung cancer (NSCLC) treated with chemoradiotherapy.